Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026
Geron Corp GERN
News
Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Geron Corporation to Participate in the Stifel 2026 Healthcare Conference
Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Kuehn Law Encourages Investors of Geron Corporation to Contact Law Firm
Geron to Present at Upcoming Investor Conferences
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
United States